Background
==========

Low levels of vitamin D have been suggested to have a negative effect on the pancreatic β cell function, being associated with insulin resistance and an increase in inflammatory markers in diabetic patients. However, the relationship between vitamin D levels and diabetes microvascular complications has not been well established yet.

Objective
=========

This study aimed to evaluate the association between the levels of 25-hydroxyvitamin D \[25(OH)D\] and the presence of cardiovascular autonomic neuropathy (CAN) in patients with type 1 Diabetes Mellitus (T1D).

Materials and methods
=====================

We performed a cross-sectional study including 50 patients with T1D, submitted to the dosage of 25(OH)D levels by chemiluminescence and to computerized autonomic tests for the evaluation of CAN. The severity of CAN was graduated in absent, incipient or established.

Results
=======

Our results showed a correlation of 25(OH)D levels with the presence and severity of CAN in patients with T1D. Patients with established CAN presented lower levels of 25(OH)D in comparison to those without CAN (21.5±7.9 vs 31.5±11.3 ngmL, respectively; p\<0.05). Evaluating the severity of CAN, we observed lower levels of 25(OH)D in patients with established CAN compared to those with incipient CAN or absence of CAN (18.6±6.4 vs 31.5±11.3 ngmL, respectively; p\<0.05). Additionally, the levels of 25(OH)D were correlated with CAN through 6 of the 7 parameters used in the diagnosis: FMB (r=0.28, p\<0.05), FB (r=0.33, p\<0.01), FA (r=0.35, p\<0.01), Valsalva maneuver (r=0.36, p.0.01), 30: 15 coefficient (r=0.38, p\<0.01) and respiratory coefficient (r=0.31, p\<0.05).

Conclusion
==========

This is the first study suggesting the association between 25(OH)D levels with the prevalence and severity of CAN in T1D patients. Further studies are necessary to establish whether vitamin D supplementation could influence the progression of CAN in these patients.
